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Soluble aggregates of IgG and immune complexes enhance
IL-6 production by renal mesangial cells
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Department of Nephrology, University Hospital Leiden, Leiden, The Netherlands
Soluble aggregates of IgG and immune complexes enhance IL-6 pro-
duction by renal mesanglal cells. Primary rat mesangial cells (MC) were
cultured in RPMI-1640 containing 5% fetal calf serum (FCS). The cells
produced interleukin-6 (IL-6) in vitro depending on the concentration of
FCS in the medium. Binding of soluble aggregates of igG (AIgG) to MC
was visualized with AIgG coupled with aminomethyl coumarin acetic
acid (AMCA). There was a dose-dependent binding of '251-AIgG to MC
at 4°C. Scatchard analysis revealed binding of AIgG containing 20 to 24
molecules per aggregate, with an affinity of 2.2 108 M1 and a total
average number of 2.7 l0 sites per cell. The binding of AIgG or
immune complexes to MC resulted in enhanced production of IL-6 by
MC in culture. This enhanced production of IL-6 was dependent on the
concentration of AIgG. To our surprise, preparations of monomeric IgG
(mIgG) also enhanced the production of IL-6 by MC, but to a lower
extent when compared to levels induced by AIgG. Very little amounts
of aggregated F(ab')2 fragments [AF(ab')2] bound to MC and conse-
quently no significant enhancement of IL-6 release by AF(ab')2 was
seen, suggesting that IL-6 production is an Fc receptor-mediated
phenomenon. The production of IL-6 by MC is inhibitable by cyclo-
heximide, thus indicating de novo synthesis. Northern blot analysis
revealed a threefold increase in mRNA for IL-6 by AIgU in vitro. The
increase in mRNA expression was directly related to the quantity of
IL-6 released in the supernatant by MC. These results suggest that
binding of AIgG or immune complexes to MC in vivo may induce IL-6
production by MC, thus leading to proliferation of MC.
Hypercellularity and accumulation of the extracellular matrix
within the glomerulus are hallmarks of a number of glomerular
diseases. The mesangium is often involved in inflammatory
processes [1]. The mesangial cell (MC) is a specialized pericyte
of vascular smooth muscle origin and plays an important role in
many glomerular functions [2]. MC appear to be analogous to
vascular smooth muscle cells in that they possess bundles of
microfilaments which probably represent the contractile appa-
ratus of these cells. MC react in response to a number of
vasoactive agents and this ability allows the cells to modify
glomerular filtration. MC are also biosynthetically active, pro-
ducing for example neutral proteinases [3], products of arachi-
donic acid metabolism [4], platelet-derived growth factor
(PDGF) [5, 6], and different cytokines such as interleukin-i
(IL-i) [7], interleukin-6 (IL-6) [8, 9], interleukin-8 (IL-8) [10,
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Ii], colony stimulating factor (CSF) [12], granulocyte-macro-
phage colony stimulating factor (GM-CSF) [13], tumor necrosis
factor (TNF) [14], and transforming growth factor-p (TGF-3)
[151.
Classical electron microscopical studies of the mesangium
have demonstrated uptake of macromolecules by MC [16]. In
glomerulonephritis (GN), immunoglobulin deposits are fre-
quently seen in the mesangium [17]. The mechanisms involved
in the removal and processing of macromolecules were inves-
tigated in rats using horse spleen ferritin. It has been shown that
MC ingest and degrade ferritin accumulated in the extracellular
matrix [18]. Further, active trapping of heat aggregated human
immunoglobulins has been shown to occur in experimental
animal models of GN [191. In addition, IgG containing immune
complexes bound to MC in vitro via specific Fcy receptors [20].
Moreover, incubation with immune complexes led to activation
of MC, resulting in stimulation and release of superoxide anion
[4], prostaglandin E2 (PGE2) [21, 22], thromboxane B2, calcium
mobilization [211, production of platelet activation factor (PAF)
[22], CSF or macrophage chemotactic peptide-l (MCP-l) [23].
The uptake of IgG2b immune complexes in vitro by MC was
enhanced in the presence of angiotensin II [24]. Fcy receptors
on MC were up-regulated in vitro by cyclic AMP, CSF- 1 and
interferon-y (IFN-y) [25].
Histologically, some forms of GN are characterized by pro-
liferation of the mesangium, suggesting the involvement of
growth factors for MC in the pathogenesis of GN. Recently it
has been suggested that IL-6 is a possible autocrine growth
factor for rat MC [8, 9]. In patients with mesangial proliferation,
IL-6 levels in urine tend to increase with the degree of severity
of GN [8, 26, 27]. On the other hand, Gordon showed that
urinary IL-6 was not specific for mesangial hypercellularity
[28]. A correlation between the production of IL-6 and mesan-
gioproliferative glomerulonephritis was shown in an in vivo
mouse model; mice transfected with the human IL-6 gene not
only had high plasma concentrations of IL-6 but also showed a
profound mesangial proliferation [29]. This potential linkage
suggests that an increased systemic production of IL-6 in the
mesangium may be responsible for the pathological prolifera-
tion of MC in GN.
Since previous studies have indicated that MC have Fey
receptors and that these cells produce IL-6, we investigated the
effect of aggregated IgG and immune complexes on the produc-
tion of IL-6 by rat MC in vitro.
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Methods
Materials
Collagenase type Ia, pepsin, trypsin, FITC-phalloidin, cyclo-
heximide (Sigma Chemical Company, St. Louis, Missouri,
USA), aminomethyl coumarin acetic acid (AMCA) (Sanbio,
Uden, The Netherlands), RPMI-1640, Iscoves modified Dulbec-
co's medium (IMDM) (Seromed, Biochrom K.G., Berlin, Ger-
many), J3-mercaptoethanol (Merck, Amsterdam, The Nether-
lands), fetal calf serum (FCS) (Gibco BRL, Grand Island, New
York, USA), penicillin and streptomycin (Boehringer Mann-
heim Gmbh, Mannheim, Germany), Sephadex G150, Sephadex
G25, Protein-A Sepharose (Pharmacia, Woerden, The Nether-
lands) were used. 3H-thymidine, Na!125, 32P (The Radiochem-
ical Centre, Amersham, Bucks, UK), lodobeads (Pierce Chem-
ical Co., Rockford, Illinois, USA), rabbit anti-human factor
VIII (Dakopatts, Kopenhagen, Denmark) were purchased as
indicated. Normal rat serum (NRS) was obtained from clinically
normal rats and stored at —20°C. T-celi growth factor (TCGF)
was prepared from stimulated human peripheral blood mono-
nuclear cells (PBMC) as described [30]. Polyclonal antibodies
against human serum albumin (HSA) were produced in our own
institute by immunizing a rabbit with HSA in complete Freunds
adjuvant. Mouse monoclonal anti-human-cytokeratin antibod-
ies and mouse monoclonal anti-rat-Thy I were provided by Dr.
E. de Heer (Dept. of Pathology, Univ. of Leiden, The Nether-
lands). Human rIL-6 was a gift from Dr. L.A. Aarden (CLB,
Amsterdam, The Netherlands).
Isolation of rat IgG, preparation of aggregated IgG and
preparation of F(ab')2
IgG was purified from sera of normal Lewis rats [31]. To
obtain AIgG, purified IgG was heat aggregated for 20 minutes at
63°C at a concentration of 10 mglml in PBS [32]. Insoluble
aggregates were removed by centrifugation for 10 minutes at
3,000 rpm. Soluble aggregates were stored at —80°C at a
concentration of 10 mg/mi.
F(ab')2 were obtained after pepsin digestion 2% wt/vol as
described before [32]. F(ab')2 were absorbed over a protein-A
Sepharose column in 1.5 M glycine, 3 M NaC1 pH 8.9, following
concentration to 3 mglml, dialyzed against PBS and aggregated
by heat treatment as described above. AF(ab')2 were then
aliquoted and frozen at —80°C until use.
Immune complexes
Immune complexes were prepared by incubation of 500 jsl
USA (250 pg/ml in PBS) and 500 d heat-inactivated rabbit-anti-
HSA serum (50%, 25% and 12.5%) for one hour at 37°C
followed by one hour at 4°C. Controls consisted of anti-HSA
serum and heat-inactivated normal rabbit serum alone. Immune
complexes were kept at 4°C and used within two weeks after
preparation. All preparations were negative when tested for
LPS contamination with the limulus amoebocyte lysate assay
[33].
Radioiodination and aggregation of IgG and F(ab')2
Purified rat IgG and F(ab')2 were radiolabeled with 125! in the
presence of lodobeads for 20 minutes at room temperature to a
specific activity of approximately 3 Ci/g protein. Protein
bound iodine was separated from free iodine by extensive
dialysis against PBS. Radiolabeled IgG (50 mg/ml) and F(ab')1
were heat aggregated for 20 minutes at 63°C. The '251-AIgG and
1251-AF(ab'), were separated according to size by ultracentrif-
ugation in 12.8 ml linear gradients of 10 to 30% sucrose in
RPMI-1640 containing 0.5% BSA [31]. In the present study
AIgG and AF(ab')2 containing an average of 20 to 24 IgG
(AIgG224) or F(ab')2 [AF(ab'),.224] molecules per aggregate
were used and all fractions were stored at —80°C.
Conjugation of IgG with AMCA
Five milligrams of aminomethyl coumarin acetic acid
(AMCA) was dissolved in 500 p1 DMSO at room temperature,
while rat IgG (11 mg/mi) was prepared in 0.5 M borate buffer pH
8.5. The rat IgG was mixed with AMCA at a concentration of
240 AMCA molecules per molecule of rat IgG, followed by
incubation for two hours at room temperature as described [31,
34]. Free fluorochrome was separated from conjugated IgG by
Sephadex G25 gel filtration. Then, conjugated rat IgG was
aggregated for 20 minutes at 63°C and stored in aliquots at
—80°C.
Mesangial cell cultures
Giomeruli were isolated from renal cortices of Sprague-
Dawley rats by mechanical dissociation and sequential sieving.
Glomerular epithelial cells were removed by digestion with type
Ia collagenase for 10 minutes at 37°C as described [35]. The
resulting glomerular suspensions were resuspended in RPM!-
1640 supplemented with 5 iO M /3-mercaptoethanol, 100
U/mI penicillin, 100 ug/ml streptomycin and 20% heat inacti-
vated FCS. The glomerular cores were plated onto plastic
culture flasks (T75, Greiner) and incubated at 37°C in 5% CO2.
After outgrowth of MC, a period of time which generally
occurred within 21 days after seeding, cells were washed,
trypsinized (0.05%) and subcultured in T75 flasks. All MC used
were obtained after the second to tenth subculture. MC repre-
sent an apparent uniform cell population as evaluated by the
following criteria: a) morphology, b) uniform fluorescence with
FITC-phalloidin for actin; c) positive staining with mouse
anti-rat Thy! for more than 98% 4% of all nucleated cells; and
d) absence of immunofluorescence using factor VIII antibodies
or antibodies for cytokeratin.
For further experiments, MC in T75 bottles were washed,
trypsinized and subcultured for the desired time period either in
12 well plates (Costar) (8 io cells/well), 48 well microtiter
plates (Costar) (2 io cells/well) or on sterile glass coverslips
(2 iO cells/well) in RPMI-1640 containing 13-mercaptoethanol
and 5% FCS.
Interleukin-6 assay
IL-6 bioactivity was measured using the IL-6 dependent
murine hybridoma cell line (B9), provided by Dr. L.A. Aarden
(CLB, Amsterdam, The Netherlands) [36]. The B9 cells were
maintained in IMDM supplemented with 5 l0 M /3-mercap-
toethanol, 0.5% TCGF, 100 U/ml penicillin, 100 jg/ml strepto-
mycin and 5% FCS. At the beginning of the assay, B9 cells were
washed three times with IMDM and 5% FCS. Cells were plated
at the cell density of 5,000 cells/well in a 96 well plate (Greiner).
Samples were titrated in twofold dilutions, rIL-6 was used as a
standard (100 U/ml). Cultures were incubated for 72 hours at
37°C in 5% CO2. Proliferation was determined by measuring the
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incorporation of 3H-thymidine (1 sCiIwel1) which was added
the last four hours of culture. Cells were harvested using an
automated cell harvester (Skatron, Lier, Norway). Radioactiv-
ity was measured with a 1217 Rackbeta counter (LKB, Woer-
den, The Netherlands). A standard curve was determined using
rIL-6, and this curve used for the calculation of the IL-6
concentration in the samples.
Visualization of binding of AIgG to MC
Trypsinized MC were cultured for another 24 hours on sterile
glass coverslips. Cells were fixed with acetone for five minutes
at 0°C and washed three times with PBS. Mter drying, the cells
were incubated with AIgG-ACMA (10 pg/ml) in PBS, PBS
alone or AMCA-AIgG in the presence of AIgG (4.3 mg/ml) for
one hour at room temperature. Slides were washed again,
mounted in 1,4 diazobicyclo(2,2,2)octane-glycerol (DABCO-
glycerol) and assessed for fluorescence at 340 to 380 nm and
photographed with a Leitz microscope (Wetzlar, Germany). All
pictures were taken under identical conditions for exactly the
same time period.
Binding of AIgG to MC
MC cultured in 48-well microtiter plates were washed three
times with PBS/0.5% BSA and incubated with various concen-
trations of 125I-AIgG2,4 or 125I-AF(ab')2;224. After 16 hours
of incubation at 4°C, the supernatants were removed and the
wells washed three times with PBS/0.5% BSA. The amount of
cell-bound radioactivity was determined by counting the radio-
activity present following cell lysis with 1 Msodium hydroxide.
The number of binding sites per cell for AIgG224 was calcu-
lated according to Scatchard [37].
Production of IL-6 by MC
The production of IL-6 in vitro was studied as follows: MC
seeded in 48-well microtiter plates were cultured for another
three to five days. Before each experiment, all wells were
washed three times with sterile PBS at 37°C; three wells were
trypsinized so that the amount of cells present at the beginning
of the assay could be counted by a Coulter counter (Coulter
Electronics, Mijdrecht, The Netherlands). MC cultured in
RPM! containing 5% FCS for 24 hours at 37°C produced low
levels of IL-6, confirming the results of a previous report [91. To
determine the effect of mIgG, AIgG, AF(ab')2 or immune
complexes on the production of IL-6 by MC, MC were incu-
bated with various concentrations of mIgG, AIgG, AF(ab')2 or
immune complexes in RPMI-1640 containing an intermediate
dose of 5% FCS at 37°C in 5% CO2 in the presence or absence
of 1 g/ml polymyxin-B. After 24 hours of incubation, super-
natants were harvested and tested for !L-6 bioactivity using the
B9 assay.
Effect of cycloheximide on the production of IL-6 by MC
Replicate wells of MC were grown in 12-well culture plates,
washed and incubated further, either in medium alone or in
medium containing 1 g/ml cycloheximide. At timed intervals,
supernatants were removed and IL-6 levels determined. Simul-
taneously, MC were harvested by trypsinization to determine
the number of cells used. Another set of MC, grown either in
normal media or media containing cycloheximide, were washed
at 72 hours of incubation and all wells were grown further in
media alone. Again, the supernatants were harvested at 72
hours and assessed for IL-6 levels. Results are expressed
relative to the number of cells present in the corresponding
wells.
Size of IL-6
Confluent MC in T75 bottles were incubated with AIgG (500
jsglml) or medium alone. After 72 hours of stimulation, super-
natants were harvested and assessed for IL-6 activity: AIgG
stimulated medium contained 2140 U/mi whereas medium con-
trol contained 70 U/mI. Two hundred microliters of superna-
tants were subjected to gel filtration using a TSK 3000 column
(LKB, Woerden, The Netherlands). Fractions of 0.3 mllmin
were collected and assessed for IL-6 activity. As a control, 200
pi human rIL-6 (1000 U/mi) was separated on TSK 3000 and
tested for IL-6 activity. The column was calibrated with alcohol
dehydrogenase (150 kD), BSA (67 kD) and carbonic anhydrase
(29 kD).
Extraction of RNA for Northern blot analysis
Confluent MC in T 175 bottles were stimulated for 72 hours
with AIgG (500 g/ml) or medium. After 72 hours, supernatants
were harvested to determine the amount of IL-6 present. The
cells were washed and subsequently used for the isolation of
total cellular RNA by phenol extraction [38]. Forty microgram
amounts of RNA were separated on formaldehyde containing
agarose gels and blotted to nitrocellulose filters (Gene-Screen
Plus, Du Pont, Wilmington, Delaware, USA). Gel electrophore-
sis, RNA transfer and hybridization of blots were done using
standard techniques [39]. The rat !L-6 cDNA probe [40] was
radiolabeled with 32P by random primed labeling [41]. To
quantitate the amount of RNA loaded per lane, the blot was
washed and rehybridized with 32P-labeled chicken p-actin
cDNA [42]. The intensity and area of density of the relevant
bands on the autoradiograms were determined with an Ultro-
scan XL (LKB, Woerden, The Netherlands).
Statistical analysis
Statistical analysis was performed using the Student t-test for
unpaired samples, and a P value of 0.05 used to determine
significance.
Results
Visualization of binding of AIgG to rat MC
MC grown on coverslips were incubated with AIgG (10
sg!ml) coupled with AMCA in the presence and absence of 4.3
mg unconjugated AIgG. Cells were incubated for one hour at
room temperature, washed, mounted and assessed for fluores-
cence. Phase contrast microscopy revealed the typical stellate
structure of MC in culture (Fig. 1A), positive fine granular
staining for rat Thy 1 (Fig. 1B), and the specific staining for
actin filaments (Fig. 1C). All MC exhibited a positive fluores-
cence with AIgG-AMCA (Fig. 1D) and binding was fully
inhibited in the presence of excess unconjugated AIgG (Fig.
lE).
Scarchard analysis
MC grown in 48-well microtiter plates were incubated with
125I-AIgG224 in concentrations ranging from 0.7 sg/well to 45
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Fig. 1. A. Phase contrast microscopy of MC in culture showing elongated cells in multilayers (200x). B. Positive fine granular staining of Thy 1
with mouse anti-rat-Thy I monoclonal antibodies (200x). C. Staining of characteristic actin filaments with FITC-phalloidin (200x). D. Positive
binding of AMCA-AIgG to MC (400x). E. Inhibition of binding of AMCA-AIgG in the presence of excess AIgG (400X).
g/we1l. After 16 hours of incubation, MC were washed and analysis of the data from four different experiments revealed an
cell-bound radioactivity was assessed. There was a dose-depen- average of 2.7 iO receptors per cell with an affinity of 2.2 108
dent saturable binding of AIgG to MC (Fig. 2 inset). Scatchard M (Fig. 2).
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Fig. 3. Production of IL-6 by MC during 24 hrs of culture in media
containing various concentrations of FCS, The results are the mean
SD of 4 experiments.
Production of IL-6 by MC
Initial experiments indicated the presence of IL-6 activity in
supernatants of MC cultured in RPMI-1640 containing 5% FCS.
To determine whether there was a relationship between FCS
concentration and basal IL-6 production, MC in 48-well micro-
titer plates were cultured in RPMI containing concentrations of
FCS ranging from 0 to 20%. A dose-dependent increase in
production of IL-6 by MC was observed in the presence of
increasing concentrations of FCS (Fig. 3). The batch of FCS
used in this study did not have IL-6 activity itself. Concentra-
tions of 10 and 20% FCS induced an optimal production of IL-6.
Further experiments were therefore performed with an inter-
mediate dose of 5% FCS.
To determine the kinetics of IL-6 production by MC, time
response experiments were performed by incubating MC in
48-well microtiter plates for 2, 4, 8, 24, 48 and 72 hours. After
incubation, the supernatants were harvested and assessed for
IL-6 activity. There was a linear increase of IL-6 production
Fig. 2. Scatchard plot analysis of binding of
'25I-AIgG224 to MC. The results are
3 expressed as mean SD of 4 experiments.
Inset: Dose-dependent and saturable binding
of 125I-AIgG224 to MC.
with time (data not shown). For convenience, a time point of 24
hours was chosen for all further experiments.
To investigate whether AIgG was able to enhance IL-6
release, MC were cultured in 48-well microtiter plates. Cells
were washed three times with PBS and incubated with increas-
ing concentrations of AIgG or mIgG ranging from 31.3 to 250
sg/ml in the presence and absence of 1 pgIml polymyxin-B.
After 24 hours of culture, supernatants were harvested and
assessed for IL-6 activity. Both AIgG and mIgG induced a
dose-dependent enhancement of IL-6 release, with AIgG being
significantly (P < 0.001) more potent than mIgG at all concen-
trations tested (Fig. 4A). These data were identical in the
presence of polymyxin-B.
The experiments suggested that some small aggregates could
have been present in the serum or were formed during the
purification procedure, also an unknown factor could have been
copurified with the IgG. Therefore, normal rat serum and
normal rat serum depleted by 80% of IgG using protein-A
absorption, were added in varying doses to MC. After 24 hours
of culture, supernatants were assessed for IL-6 activity. Nei-
ther NRS nor IgG depleted NRS by themselves had IL-6
activity. NRS at all doses tested induced IL-6 release, while
IgG-depleted NRS only induced significant IL-6 release by MC
at concentrations greater than 3.75% (Fig. 4B). An input of
3.75% IgG depleted NRS is equivalent to a concentration of
37.5 g/ml IgG.
To investigate whether the enhancement by AIgG was an
Fc-mediated phenomenon, MC were incubated with increasing
concentrations 125I-AIgG224 or '25I-AF(ab')2;224. After 16
hours of incubation at 4°C, the amount of cell-bound radioac-
tivity was assessed. There was a dose-dependent binding of
'25I-AIgG224 to MC while little binding of 125I-AF(ab')2;224
was seen which did not show a relation with the dose of input of
'25I-AF(ab')2;224 (Fig. 5). When the experiment was per-
formed with AIgG and AF(ab')2 (80 pmollml) for 24 hours at
37°C to assess the amount of IL-6 produced in the supernatants
of the treated cells, we found that AIgG enhanced the IL-6
release, while only a minimal increase in IL-6 production was
seen when cells were treated with AF(ab')2 (data not shown).
0 1 2
—
 
-
s 
t' 
a
 
13
 
M
 
a
 
0) 
0 
0 
0 
0 
0 
0 
Q 
2 
0 
0 
L) 
I.-
.?
 
0 
0 
8 
0 
0 
0 
0 
0 
w
 
I 
01
 
III
III
IIl
III
tP
I!I
III
III
III
III
III
IIF
III
IIH
 
C.
) 
C)
 
' 
80
 
11
11
1 I!
III
III
III
III
III
III
III
III
III
iII
III
I—
 
2 
0) 
—
 
_
_
_
 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
.
 
tn
 
III
III
iII
III
III
II•
 
liii
 llII
III
III
III
III
III
III
III
III
II!
III
III
—
.—
l 
M
IIl
ii1
III
III
III
IH
 
I) 
_
_
_
_
_
_
_
_
_
_
_
_
 
11
11
11
1 
III
III
III
III
III
III
III
!I!
liI
III
III
III
I—
1 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
 
11
11
11
11
11
11
1 II
III
III
III
III
lII
III
 II Il
I••
' 
h 
_
_
_
_
_
_
_
_
_
 
a
, 0 
III
III
III
III
III
III
III
iII
III
III
III
III
III
III
III
III
III
II 
I 
Co
-J
van den Dobbelsteen et a!.' JC enhance IL-6 production by MC 549
V
0
.0
C
1)0
0.
Concentration 'ug/well
Fig. 5. Dose-dependent binding of 125I-A1gG2,24 to MC; little amounts
of '25I-AF(ab')2.224 bind to MC. Symbols are: (i) AF(ab')2; ()
AIgG.
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Fig. 4. A. Effect of various concentrations of mIgG (0) and AIgG ()
on the production of IL-6 by MC. The results are the mean so of 6
experiments. B. Effect of various concentrations of normal rat serum
() and IgG depleted normal rat serum (0) on the production of IL-6
by MC. The results are expressed as the mean so of 3 experiments.
Since AIgG serves as a model for immune complexes, we
also investigated the IL-6 inducing capabilities of immune
complexes prepared at three different concentrations of anti-
serum and using a fixed concentration of HSA. Immune com-
plexes composed of rabbit anti-HSA and HSA or controls were
incubated with MC and assessed for IL-6 release after 24 hours.
HSA, normal rabbit serum or media induced less than 150 U
IL-6/105 cells by MC while immune complexes composed at
different ratios induced significantly more IL-6 release. As
compared to AIgG, immune complexes prepared with a con-
centration of 2.5% were potent activators of MC. Increasing
antibody to antigen ratios resulted in a decreased potency for
stimulation of MC (Fig. 6).
De novo synthesis of IL-6
To further investigate the production of IL-6 by MC, exper-
iments were performed in medium alone or in medium contain-
ing 1 sg/ml cycloheximide for various time periods. Figure 7A
shows a time-dependent and almost complete inhibition of IL-6
production by cycloheximide whereas non-treated cells pro-
duced IL-6 in a time-dependent fashion. To determine whether
this effect of cycloheximide was reversible, cells which had
been incubated with cycloheximide for 72 hours were washed
and cultured for another 72 hours. No significant difference was
observed in the amount of IL-6 produced by MC which had
been treated with cycloheximide or medium (Fig. 7B).
Size of IL-6
To determine the size of IL-6 produced by MC, confluent MC
in T75 flasks were stimulated with AIgG (500g/ml) or medium
for 72 hours. Two hundred microliters of supernatants were
subjected to fractionation on a TSK 3000 gel filtration column.
The different fractions were subsequently assayed using the B9
assay. IL-6 activity in supernatants of MC stimulated with
AIgG containing 2140 U/mi, exhibited an apparent molecular
weight of 40 to 43 kD (Fig. 8A). In supernatants of MC cultured
in medium alone (70 U/mi) and subjected to fractionation on a
TSK 3000 column, no B9 activity could be detected. Fraction-
ation of human rIL-6 (1000 U/mi) revealed IL-6 activity in
fractions 74—77, an elution pattern which corresponds with an
apparent molecular weight of 26 to 29 kD (Fig. 8B).
RNA message for IL-6
To investigate whether IL-6 was also up-regulated at the
RNA level, total RNA was isolated from MC which had been
preincubated either with AIgG (500 gImi) or medium. Forty
micrograms of RNA were eiectrophoresed and blotted onto
nitrocellulose; IL-6 mRNA transcripts were detected by hybrid-
ization using a specific DNA probe. The ribosomal bands were
visualized with ethidium bromide under UV light, results of
which revealed that equal amounts of RNA were loaded on
each lane. The Northern blot analysis demonstrated a 1.2 kb
and a 2.4 kb form of mRNA for rat IL-6 in both cultures (Fig. 9).
Density measurements revealed that cells which had been
incubated with AIgG had a threefold higher expression of
mRNA for IL-6 than the cells cultured in medium. Bioactivity
analysis revealed 247 95 U/mi of IL-6 present in these
cultures; AIgG induced an increase in IL-6 up to 1140 198
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Fig. 6. Induction of IL-6 production by
immune complexes prepared with various
concentrations of rabbit-anti-HSA and a fixed
concentration of HSA. Controls consisted of
antiserum alone or normal rabbit serum. The
results are expressed as the mean SD of 3
experiments. Symbols are: () medium; (i)
antiHSA + HSA; (D) antiHSA; () NRaS.
Fig. 7. Inhibition of IL-6 production by I jxg/
ml cycloheximide (—--) whereas non-treated
cells (—0—) produce a time-dependent amount
of JL-6 (A). After 72 hrs, MC which had been
incubated in medium alone () or medium
with cycloheximide (VA), were cultured further
in medium alone and assessed for IL-6. The
results are expressed as the mean SD of 4
experiments.
U/mi, values which represent a stimulation of 4.6-fold over
control. The blot was washed and subsequently rehybridized
with a chicken -actin DNA probe. The autoradiogram of the
Northern blot demonstrated comparable amounts of the 2.0 kb
form of mRNA for rat actin.
Discussion
Binding of immune complexes to rat MC has been described
by a number of investigators [4, 20—25]. In the present study we
demonstrate that soluble aggregates of IgG also bind to MC in
a dose-dependent fashion.
AIgG was chosen as a model for immune complexes because
it has been shown that these aggregates remain stable in time
and have many biological properties of immune complexes [32].
Using AIgG224, an average number of 2.7 i05 binding sites
per MC was found with an affinity of 2.2 108 M1. Our results
are at least two times higher than the number of receptors
reported by Sedor, Carey and Emancipator [4], while the
affinity we evaluated was more than 100-fold higher. These
discrepancies may be explained by the difference in size of the
probe used for the assessment of the number of receptors and
the calculation of their affinity. In the present study, AIgG with
a size of 3 106 kD was used, while Sedor et al used immune
complexes with a size of 750 kD. Furthermore, immune corn-
plexes may be in dynamic equilibrium with antigen such that
interference by mIgG is possible. Both our as well as previous
results indicate the presence of only one type of functional
receptor for IgG on MC. These findings are in agreement with
recent reports that polyclonal and monoclonal anti-Fcy recep-
tor only precipitate one species of Fcy receptors from rat MC
[20, 25].
The coincubation of AIgG with MC resulted in enhanced
production of IL-6 by MC in vitro. This effect is time- and
dose-dependent. To our surprise, preparations of purified mIgG
were able to enhance the production of IL-6 by MC. Although
mIgG was less effective than AIgG, it was reasoned that small
aggregates can be present in NRS or preparations of purified
IgG. Another possibility is that an unknown factor is copurified
with IgG, a factor which potentially should also be sensitive to
pepsin digestion since its activity is decreased in AF(ab')2
preparations. To clarify this point, IgG was partially removed
from rat serum and this IgG depleted serum was assessed for
the production of IL-6 by MC. IgG depletion indeed resulted in
abrogation of the IL-6 response, but at higher concentrations of
IgG depleted NRS there still was detectable IL-6 production.
This amount of IL-6 production was related to the concentra-
tion of IgG still present in the depleted serum. When normal
rabbit serum (NRaS) was added to MC in culture, this serum
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was less potent in enhancing IL-6 production when compared
with normal rat serum. Ten percent NRaS induced an average
of 150 U IL-6/105 cells, whereas 10% NRS induced an average
of 800 U IL-6/105 cells. These differences may be dependent on
the binding affinities of the Fey receptor for rat IgG and rabbit
IgG, or on the differences in the degree of aggregation of rat IgG
or rabbit IgG in whole serum.
To investigate the mechanism of binding of immune com-
plexes to MC, we prepared AF(ab')2; little amounts of these
aggregates bound to MC and no significant enhancement of IL-6
release by MC were seen with AF(ab')2, suggesting an Fc
dependent triggering of MC. These data are in agreement with
previous reports [4, 20—23] that MC express one type of Fcy
receptor which can only interact with intact immune complexes
via the Pc part of the molecules.
The increased sensitivity of cultured MC to rat IgG, may
reflect activation of MC in culture, a feature which may be
different from the situation in vivo. To elucidate this point,
mRNA studies of freshly isolated MC and cultured MC are
required. The enhanced IL-6 production by MC in vitro in
response to mIgG, AIgG or immune complexes is in agreement
with the increased generation of superoxide anions [4], PGE2
[21, 22], PAF [22], thromboxane B2 [21], calcium mobilization
[21], CSF and MCP-l [23].
In vivo, immune complex ON may be associated both with
MC proliferation and an increase in matrix production [17]. Our
observation that AIgG or immune complexes induce IL-6
production and the previous observation that IL-6 is an auto-
crine growth factor for MC [8, 9] suggest that deposition of
immune complexes may be directly responsible for these two
biological effects. In vivo studies in which MC are directly
triggered with specific cellular antibodies and determination of
IL-6 production in situ, to our knowledge have not been
reported yet.
The apparent size of IL-6 produced by MC as determined by
gel filtration is 43 kD, while human rIL-6 filtered with an
apparent molecular weight of 26 kD. The size of rat IL-6 in the
present study is in agreement with the size reported by others
[91 and may indicate either dimerization of the molecule or
exaggerated carbohydrate substitution. The size of mRNA for
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Fig. 8. Determination of the size of rat IL-6
by TSK 3000 fractionation of supernatants
from MC stimulated with 500 igImI AIgG.
Symbols are: (. . .) OD 700; (—0—) MC IL-6;
(—is—) rIL-6, As a control, human rIL-6 was
fractionated on the same column; the
molecular weight markers, alcohol
dehydrogenase, BSA and carbonic anhydrase
were used.
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known to be an autocrine growth factor for MC [8, 9]. In vivo
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